Literature DB >> 2836199

Hormonal regulation of low-density lipoprotein (LDL) receptor activity in human hepatoma Hep G2 cells. Insulin increases LDL receptor activity and diminishes its suppression by exogenous LDL.

D P Wade1, B L Knight, A K Soutar.   

Abstract

Low-density lipoprotein (LDL) receptors of approximate Mr 130,000 on non-reduced gels have been identified in Hep G2 cells by immuno- and ligand-blotting of cell extracts. Measurement of LDL receptor protein by scanning ligand blots was correlated with the specific binding, uptake and degradation of 125I-labelled LDL by intact cells, confirming that this is mediated by the LDL receptor. Cells incubated in medium with serum expressed significant LDL receptor activity. This increased when cells were transferred to medium containing lipoprotein-deficient serum (LPDS) but was not maximal because a further increase occurred when compactin was included in the medium. Inclusion of 17 alpha-ethinyl estradiol or 17 beta-estradiol in the medium at concentrations up to 500 ng/ml had no effect on LDL receptor activity in the cells as assayed by ligand blotting. Inclusion of insulin (100 mU/ml) in the preincubation medium containing LPDS resulted in a twofold increase in LDL-receptor protein and of LDL binding and degradation by intact cells. Insulin also diminished the suppressive effect of LDL on LDL receptor activity. If insulin exerts this effect in vivo it may partly explain why the liver expresses LDL receptors despite high levels of LDL in plasma and interstitial fluid.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836199     DOI: 10.1111/j.1432-1033.1988.tb14084.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  14 in total

1.  Co-ordinate regulation of low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase and synthase gene expression in HepG2 cells.

Authors:  D T Molowa; G M Cimis
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

2.  Synthesis and properties of the very-low-density-lipoprotein receptor and a comparison with the low-density-lipoprotein receptor.

Authors:  D D Patel; R A Forder; A K Soutar; B L Knight
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

Review 3.  Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review.

Authors:  Petter Bjornstad; Robert H Eckel
Journal:  Curr Diab Rep       Date:  2018-10-17       Impact factor: 4.810

4.  Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs.

Authors:  Rozh H Al-Mashhadi; Martin M Bjørklund; Martin B Mortensen; Christina Christoffersen; Torben Larsen; Erling Falk; Jacob F Bentzon
Journal:  Diabetologia       Date:  2015-05-31       Impact factor: 10.122

5.  Glucagon, cyclic AMP and adrenaline stimulate the degradation of low-density lipoprotein by cultured rat hepatocytes.

Authors:  N F Brown; A M Salter; R Fears; D N Brindley
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

6.  Estradiol regulates insulin dependent stimulation of LDL-receptor expression in HepG(2) cells.

Authors:  R Gopalakrishnan; N C Chandra
Journal:  Indian J Clin Biochem       Date:  2006-03

7.  Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studies.

Authors:  Dick C Chan; P Hugh R Barrett; Gerald F Watts
Journal:  Clin Biochem Rev       Date:  2004-02

8.  Stimulation of low-density lipoprotein uptake in HepG2 cells by epidermal growth factor via a tyrosine kinase-dependent, but protein kinase C-independent, mechanism.

Authors:  A Graham; L J Russell
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

9.  Dose and time-dependent hypercholesterolemic effects of iodine excess via TRbeta1-mediated down regulation of hepatic LDLr gene expression.

Authors:  Li-Na Zhao; Jian Xu; Xiao-Lin Peng; Li-Yue Tian; Li-Ping Hao; Xue-Feng Yang; Chen-Jiang Ying; Xiu-Fa Sun
Journal:  Eur J Nutr       Date:  2009-11-16       Impact factor: 5.614

10.  Removal from the plasma of the free and esterified forms of cholesterol and transfer of lipids to HDL in type 2 diabetes mellitus patients.

Authors:  Carolina P Oliveira; Raul C Maranhão; Marina P Bertato; Bernardo L Wajchenberg; Antonio C Lerario
Journal:  Lipids Health Dis       Date:  2012-06-07       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.